Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

Global private equity and venture capital investments in pharmaceutical companies lag 2024 figures, and regulatory headwinds ...

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quarter, EBITDA stood at Rs 3,716.1 ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the ...

Rising drug costs are shaking the foundation of Michigan’s health care industry, with the potential to push the market to ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

U.S. President Donald Trump's trade negotiators are pushing the EU to make unilateral tariff reductions on U.S. goods, saying ...